Detection of cell‐free DNA fragmentation and copy number alterations in cerebrospinal fluid from glioma patients
Abstract Glioma is difficult to detect or characterize using current liquid biopsy approaches. Detection of cell‐free tumor DNA (cftDNA) in cerebrospinal fluid (CSF) has been proposed as an alternative to detection in plasma. We used shallow whole‐genome sequencing (sWGS, at a coverage of < 0.4×)...
Main Authors: | Florent Mouliere, Richard Mair, Dineika Chandrananda, Francesco Marass, Christopher G Smith, Jing Su, James Morris, Colin Watts, Kevin M Brindle, Nitzan Rosenfeld |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-12-01
|
Series: | EMBO Molecular Medicine |
Subjects: | |
Online Access: | https://doi.org/10.15252/emmm.201809323 |
Similar Items
-
Fragmentation patterns and personalized sequencing of cell‐free DNA in urine and plasma of glioma patients
by: Florent Mouliere, et al.
Published: (2021-08-01) -
Angiogenic potential of the cerebrospinal fluid (CSF) of patients with high-grade gliomas measured with the chick embryo chorioallantoic membrane assay (CAM)
by: Mariana Sinning, et al.
Published: (2012-01-01) -
Application of MGMT Promoter Methylation of Cerebrospinal Fluid in Diagnosis of Glioma
by: WANG Long, et al.
Published: (2018-10-01) -
Correlation of Metabolic Profiles of Plasma and Cerebrospinal Fluid of High-Grade Glioma Patients
by: A. D. Rogachev, et al.
Published: (2021-02-01) -
A Protein Microarray-Based Investigation of Cerebrospinal Fluid Reveals Distinct Autoantibody Signature in Low and High-Grade Gliomas
by: Nikita Gahoi, et al.
Published: (2020-12-01)